Study Stopped
Absence of key personnel to conduct study
MRI Laryngeal Imaging With a Surface Coil
High Resolution MRI in the Evaluation of Laryngeal Neoplasia
3 other identifiers
interventional
3
1 country
1
Brief Summary
To determine if high resolution MRI can detect early invasion of cartilage by laryngeal carcinoma, and to determine if high resolution MRI may be superior to conventional MRI imaging or CT imaging to detect cartilage invasion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Jul 2009
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 21, 2009
CompletedFirst Posted
Study publicly available on registry
August 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedOctober 5, 2017
October 1, 2017
6 months
August 21, 2009
October 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Tumor stage as determined by HRMRI.
Radiologic tumor stage
24 to 48 hours
Secondary Outcomes (2)
Estimate the precision of HRMRI in discriminating between edema and tumor in patients with prior radiotherapy or chemotherapy.
4 to 6 weeks
Tumor stage as determined by histopathology in excised larynges.
4 to 6 weeks
Study Arms (1)
MRI scan with surface coil
EXPERIMENTALPatients with known laryngeal cancer, with suspected cartilage involvement by conventional computed tomography scanning, who undergo high resolution magnetic resonance imaging enhanced with a surface coil placed over the larynx.
Interventions
Standard of Care
Eligibility Criteria
You may qualify if:
- Patients with benign or malignant neoplasm of the larynx.
- Patients who have undergone prior surgery, radiation therapy, or chemotherapy for cancer of the laryngopharynx will be eligible to participate.
- Patients 18 years of age and older at time of evaluation, male and female, all ethnicities.
- Ability to understand and the willingness to sign a written informed consent document.
You may not qualify if:
- Pregnancy
- Claustrophobia.
- Anatomic parameters which preclude scanning, such as limited range of neck motion, or inability to remain flat for at least 15 minutes.
- Patients with implanted devices (eg, defibrillator, pacemaker) that are a known contraindication to magnetic resonance imaging.
- Allergy to gadolinium contrast.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edward J. Damrose MD, FACS
Stanford University
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Otolaryngology
Study Record Dates
First Submitted
August 21, 2009
First Posted
August 25, 2009
Study Start
July 1, 2009
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
October 5, 2017
Record last verified: 2017-10